See the Full Picture.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Eid
Elon Musk
Donald Trump
Social Media
Artificial Intelligence
Tesla
Soccer
World Cup
Apple
European Union
Stock Markets
Natural Disasters
Published • loading... • Updated

Preliminary Data from Two Clinical Trials with ADC Candidates were Presented Orally at the 2025 ASCO Annual Meeting

Summary by The Victoria Advocate
SHANGHAI and CHICAGO, June 4, 2025 /PRNewswire/ -- The 2025 ASCO Annual Meeting is taking place in Chicago, US, from May 30 to June 3. Duality Bio (HKEX: 9606.HK) presented the preliminary data of two clinical trials, HER3 ADC candidate…

4 Articles

All
Left
1
Center
Right
The Victoria AdvocateThe Victoria Advocate
+2 Reposted by 2 other sources
Lean Left

Preliminary Data from Two Clinical Trials with ADC Candidates were Presented Orally at the 2025 ASCO Annual Meeting

SHANGHAI and CHICAGO, June 4, 2025 /PRNewswire/ -- The 2025 ASCO Annual Meeting is taking place in Chicago, US, from May 30 to June 3. Duality Bio (HKEX: 9606.HK) presented the preliminary data of two clinical trials, HER3 ADC candidate…

Read Full Article
European Pharmaceutical ManufacturerEuropean Pharmaceutical Manufacturer

Enterome presents new positive data at ASCO 2025

Enterome SA presented new positive data from its ongoing Phase 1/2 “AUDREY” trial of its OncoMimics immunotherapy, EO4010, at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

European Pharmaceutical Manufacturer broke the news in on Wednesday, June 4, 2025.
Sources are mostly out of (0)

Similar News Topics

Chicago, IL

Chicago, IL

News
For You
SearchBlindspotLocal